Exogenous Administration of a Recombinant Variant of TWEAK Impairs Healing after Myocardial Infarction by Aggravation of Inflammation

BACKGROUND: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor fibroblast growth factor-inducible 14 (Fn14) are upregulated after myocardial infarction (MI) in both humans and mice. They modulate inflammation and the extracellular matrix, and could therefore be important f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachel, Christina, Mathes, Denise, Bayer, Barbara, Dienesch, Charlotte, Wangorsch, Gaby, Heitzmann, Wolfram, Lang, Isabell, Ardehali, Hossein, Ertl, Georg, Dandekar, Thomas, Wajant, Harald, Frantz, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823964/
https://www.ncbi.nlm.nih.gov/pubmed/24244389
http://dx.doi.org/10.1371/journal.pone.0078938

Ejemplares similares

Ejemplares similares